BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 3, 2009
View Archived Issues
Recent Roche patent describes new NNRTIs for HIV infection
Read More
GlaxoSmithKline divulges new calcium receptor antagonists for osteoporosis
Read More
New CaSR antagonists discovered by Pfizer researchers
Read More
Novel microtubule-stabilizing agents discovered by the University of Pennsylvania and Kosan
Read More
Novel tachykinin NK1 receptor antagonists identified by Merck & Co. researchers
Read More
Recent Takeda patent reports new renin inhibitors with antihypertensive properties
Read More
Synta completes enrollment in phase III SYMMETRYSM trial
Read More
Auxilium completes enrollment in phase IIb Xiaflex trial
Read More
Phase II IMPACT-DCM clinical trial of Aastrom's CRCs placed on clinical hold after SAE
Read More
New DPP-4 inhibitors discovered by Santhera and Biovitrum researchers
Read More
Rexahn initiates phase IIa clinical trial of Serdaxin in major depressive disorder
Read More
Cephalon exercises option to license worldwide rights to ImmuPharma's Lupuzor for SLE
Read More
Researchers report development of tetracyclic indole inhibitors of HCV NS5B-polymerase
Read More
Medarex receives milestone payment from MedImmune for allowance of IND for MEDI-546
Read More
Drug delivery innovation: Selective release of DNA oligonucleotides from gold nanorods with lasers
Read More
Acorda submits NDA for Fampridine-SR for walking improvement in MS
Read More
Cenix collaborates with Boehringer Ingelheim for RNAi-based target discovery
Read More
Idera achieves clinical milestone under cancer collaboration with Merck KGaA
Read More
Anavex scales up Anavex 2-73 for phase I Alzheimer's disease study
Read More
Ligand announces phase IIb results for PS4-33540 in hypertension
Read More
Phase III study shows Tarceva plus Avastin improves survival in lung cancer
Read More
Safinamide significantly improved motor function in Parkinson's disease
Read More
Medgenics presents positive data from phase I/II Epodure trial in anemia
Read More
ESBATech advances antibody fragment into phase Ib/IIa trials in ophthalmology
Read More
Transcept completes merger with Novacea
Read More